Statement
11 Mar 2024
Delivering equitable access in pandemics: Biopharmaceutical industry commitments
In response to the threat of future global pandemics, the biopharmaceutical industry developed a set of commitments for equitable access to essential medical countermeasures in future pandemics.
Read more
Statement
8 Mar 2024
Resumed session of the 7th Meeting of the Working Group on Amendments to the International Health Regulations (2005)
On 8 March 2024, IFPMA delivered a statement at the resumed session of the 7th Meeting of the Working Group on Amendments to the International Health Regulations in Geneva, where the focus of discussions was on equity.
Read more
Statement
6 Feb 2024
IFPMA statement ahead of the opening of the fourth WHO Fair Pricing Forum
The fourth meeting of the WHO’s Fair Pricing Forum represents an important opportunity to discuss how the global health community can work together to improve access to medicines and vaccines, deliver on the ambition of the Sustainable Development Goals (SDGs), and to achieve Universal Health Coverage (UHC) by 2030. IFPMA and our members continue to be committed to these goals and welcome the opportunity to share perspectives on how we can work together to achieve them.
Read more